2916
H.-S. Oh, J. K. Cha / Tetrahedron: Asymmetry 14 (2003) 2911–2917
was dissolved in CH2Cl2 (20 mL) and washed with 10%
potassium fluoride solution (10 mL), dried (MgSO4),
filtered, and concentrated. Purification by column chro-
matography on silica gel (15:1 hex–EtOAc) gave 6a
Representative procedure for radical allylation: A solu-
tion of allyltributyltin (102 mg, 0.3 mmol) and AIBN (6
mg, 0.04 mmol) in benzene (1 mL) was added, over a
period of 6 h (syringe pump), to a solution of 4a (the
more polar isomer; 30 mg, 0.1 mmol) in benzene (1 mL)
at reflux. The reaction mixture was cooled to rt and
concentrated under reduced pressure. The residue was
then dissolved in CH2Cl2 (30 mL) and washed with 10%
potassium fluoride solution (10 mL), dried over
MgSO4, filtered, and concentrated to give the crude
product. Purification by column chromatography on
silica gel (15:1 hex–EtOAc) afforded 9 (24 mg, 96%) as
1
(14.3 mg, 99%): IR (film) 1699 cm−1; H NMR (360
MHz, CDCl3) l 1.02–1.47 (m, 6H), 1.51–1.90 (m, 6H),
2.09 (ddd, J=12.3, 6.6, 3.7 Hz, 1H), 2.18 (m, 1H), 2.29
(ddd, J=15.6, 6.5, 3.6 Hz, 1H), 2.44 (dt, J=2.7, 12.3
Hz, 1H), 2.59 (m, 1H), 2.92 (dt, J=3.1, 11.7 Hz, 1H),
3.20 (m, 1H), 3.34 (s, 3H); 13C NMR (90 MHz, CDCl3)
l 23.7, 26.6, 26.7, 30.1, 31.7, 32.9, 35.2, 38.9, 41.7, 44.8,
58.1, 85.4, 218.3; MS m/z 210 (M+).
1
a 5:1 diastereomeric mixture: IR (film) 1704 cm−1; H
1
6b-a. IR (film) 1698 cm−1; H NMR (360 MHz, CDCl3)
NMR (360 MHz, CDCl3) l 1.09–1.44 (m, 6H), 1.52–
1.75 (m, 5H), 1.78 (dd, J=5.3, 3.2 Hz, 1H), 1.81–1.91
(m, 2H), 2.10 (m, 1H), 2.41 (dt, J=14.1, 6.8 Hz, 1H),
2.45–2.57 (m, 2H), 2.78 (m, 1H), 3.25 (s, 3H), 3.41 (m,
1H), 5.01 (dd, J=9.9, 1.5 Hz, 1H), 5.03 (dd, J=17.2,
1.5 Hz, 1H), 5.72 (m, 1H); 13C NMR (90 MHz, CDCl3)
l 26.3, 26.6 (2 C’s), 32.5, 34.6, 35.8, 36.7, 38.9, 42.0 (2
C’s), 46.1, 56.9, 83.5, 116.9, 136.1, 216.4; MS m/z 250
(M+).
l 1.16 (m, 1H), 1.26–1.73 (m, 6H), 1.82 (m, 2H), 1.96
(m, 1H), 2.11–2.31 (m, 4H), 2.60 (m, 1H), 2.79 (dt,
J=11.5, 3.5 Hz, 1H), 2.99 (dt, J=2.7, 10.3 Hz, 1H),
3.30 (s, 3H); 13C NMR (90 MHz, CDCl3) l 23.4, 25.7,
29.9, 33.2, 36.4, 39.0, 40.0, 41.9, 47.5, 57.0, 84.7, 218.4.
1
6b-b. IR (film) 1701 cm−1; H NMR (360 MHz, CDCl3)
l 1.15 (m, 1H), 1.25–1.68 (m, 6H), 1.78–1.88 (m, 1H),
1.91–1.98 (m, 1H), 2.02–2.30 (m, 5H), 2.44 (m, 1H),
2.78 (dt, J=3.6, 11.7 Hz, 1H), 3.17 (m, 1H), 3.39 (s,
3H); 13C NMR (90 MHz, CDCl3) l 26.5, 26.6, 28.5,
32.2, 36.4, 38.1, 39.9, 41.1, 47.0, 58.0, 82.7, 217.7.
1
12. IR (film) 1711 cm−1; H NMR (360 MHz, CDCl3) l
0.90 (m, 1H), 1.16 (m, 1H), 1.35–1.55 (m, 3H), 1.58–
1.68 (m, 2H), 1.78 (m, 2H), 1.92–2.25 (m, 6H), 2.62 (m,
1H), 2.77 (m, 1H), 2.96 (dt, J=10.0, 2.8 Hz, 1H), 3.28
(s, 3H), 5.04 (dd, J=17.9, 1.2 Hz, 1H), 5.05 (dd,
J=10.1, 1.2 Hz, 1H), 5.71 (m, 1H); 13C NMR (90
MHz, CDCl3) l 25.7, 29.4, 33.4, 36.3, 36.4, 37.9, 38.0,
41.9, 47.6, 48.1, 56.9, 84.3, 117.4, 135.3, 218.9.
1
7a-a. IR (film) 1702 cm−1; H NMR (400 MHz, CDCl3)
l 1.30–1.40 (m, 2H), 1.42–1.54 (m, 4H), 1.58–1.66 (m,
2H), 1.76 (m, 1H), 1.96–2.15 (m, 3H), 2.44–2.47 (m,
2H), 2.74–2.75 (m, 2H), 3.32 (m, 1H), 3.34 (s, 3H); 13C
NMR (100 MHz, CDCl3) l 22.2, 24.4, 25.5, 26.5, 34.1,
35.6, 43.0, 43.3, 43.8, 56.8, 80.3, 212.9; HRMS calcd for
C12H20O2Na (M+) 219.1355, found 219.1354.
1
13. IR (film) 1698 cm−1; H NMR (360 MHz, CDCl3) l
0.90 (m, 1H), 1.15 (m, 1H), 1.42–1.68 (m, 5H), 1.77–
1.98 (m, 4H), 2.00–2.30 (m, 5H), 2.76 (m, 1H), 3.14
(ddd, J=10.7, 5.1, 3.0 Hz, 1H), 3.36 (s, 3H), 5.04 (dd,
J=17.2, 1.4 Hz, 1H), 5.05 (dd, J=10.1, 1.4 Hz, 1H),
5.71 (m, 1H); 13C NMR (90 MHz, CDCl3) l 26.5, 31.8,
32.9, 36.2, 36.4, 38.0, 38.2, 38.4, 46.9, 51.2, 58.1, 82.1,
117.6, 135.0, 219.2.
1
7a-b. IR (film) 1702 cm−1; H NMR (500 MHz, CDCl3)
l 1.24–1.42 (m, 3H), 1.46–1.50 (m, 1H), 1.52 (m, 1H),
1.59–1.62 (m, 3H), 1.80 (m, 1H), 1.90 (m, 1H), 1.99 (m,
1H), 2.13 (m, 1H), 2.41 (dd, J=14.7, 3.0 Hz, 1H), 2.44
(m, 1H), 2.63 (dd, J=16.5, 5.1 Hz, 1H), 2.67 (dd,
J=16.5, 10.1 Hz, 1H), 3.33 (s, 3H), 3.55 (ddd, J=10.1,
5.1, 2.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) l 20.4,
21.7, 25.2, 26.6, 34.5, 38.7, 43.5, 44.2, 45.2, 56.9, 80.4,
211.7; HRMS calcd for C12H20O2Na (M+) 219.1355,
found 219.1358.
(4R, 5R)-2-Bromoethyl-4,5-diphenyl-1,3-dioxolane 21: A
mixture of (R,R)-(+) hydrobenzoin (950 mg, 4.43
mmol) and 3-bromopropionaldehyde diethylacetal (900
mg, 4.27 mmol) was heated at 135–145°C for 2 h and
then cooled. The product was recrystallized from iso-
1
1
8. IR (film) 1702 cm−1; H NMR (360 MHz, CDCl3) l
propanol to give 21 (1.3 g, 91%) as a white solid: H
1.03–1.35 (m, 5H), 1.45 (m, 1H), 1.53–1.70 (m, 5H),
1.72–1.81 (m, 1H), 2.08 (m, 1H), 2.19 (dt, J=5.7, 14.7
Hz, 1H), 2.31 (ddd, J=15.7, 6.6, 3.6 Hz, 1H), 2.45 (m,
1H), 2.61 (m, 1H), 3.21 (m, 1H), 3.36 (s, 3H); 13C NMR
(90 MHz, CDCl3) l 26.6, 26.7, 30.1, 31.6, 32.9, 34.1,
34.8 (t), 38.9, 41.7, 44.8, 58.0, 85.5, 218.3; HRMS calcd
for C13H21DO2 (M+) 211.1683, found 211.1657.
NMR (400 MHz, C6D6) l 2.21 (dt, J=7.3, 4.9 Hz, 2H),
3.30 (t, J=7.3 Hz, 2H), 4.56 (d, J=8.1 Hz, 1H), 4.60
(d, J=8.1 Hz, 1H), 5.44 (t, J=4.9 Hz, 1H), 7.00–7.20
(m, 10H); 13C NMR (100 MHz, C6D6) l 27.2, 38.1,
85.2, 87.1, 103.7, 126.6, 127.0, 128.5, 128.6; GC-MS
m/z 333 (M+).
22 (the major isomer; the less polar fraction): IR (film)
1
1
11. IR (film) 1698 cm−1; H NMR (360 MHz, CDCl3) l
1765 cm−1; H NMR (500 MHz, CDCl3) l 0.86 (m,
1.16 (m, 1H), 1.35–1.73 (m, 6H), 1.80 (m, 2H), 1.95 (m,
1H), 2.13–2.19 (m, 1H), 2.21–2.30 (m, 2H), 2.56 (m,
1H), 2.80 (m, 1H), 2.99 (dt, J=10.1, 2.9 Hz, 1H), 3.30
(s, 3H); 13C NMR (90 MHz, CDCl3) l 23.3, 25.7, 33.3,
36.4, 38.7 (t; another small triplet at 38.6), 38.9, 40.0,
41.9, 47.5, 57.0, 84.7, 217.2; HRMS calcd for
C12H19DO2 (M+) 197.1526; found 197.1557.
1H), 1.14–1.35 (m, 2H), 1.44–1.52 (m, 2H), 1.66–1.74
(m, 3H), 1.78 (m, 1H), 1.96–2.08 (m, 3H), 2.28 (m, 1H),
3.15–3.29 (m, 3H), 3.44 (dt, J=6.1, 10.6 Hz, 1H), 3.49
(dt, J=5.0, 10.6 Hz, 1H), 4.31 (d, J=8.1 Hz, 1H), 4.75
(d, J=8.1 Hz, 1H), 7.01 (m, 2H), 7.07 (m, 2H), 7.14 (m,
3H), 7.25 (m, 3H); 13C NMR (125 MHz, CDCl3) l
18.3, 22.0, 25.3, 26.2, 26.6, 32.4, 34.1, 42.2, 43.1, 67.0,